Anais Elewaut
@aelewaut.bsky.social
140 followers 120 following 1 posts
Postdoc in the @Kaech lab at the Salk Institute. Previously PhD student @Obenauf lab at the IMP in Vienna. Interested in #immuno-oncology#gbm#neuroscience
Posts Media Videos Starter Packs
Pinned
aelewaut.bsky.social
Extremely excited to see my PhD work in the @obenaufa.bsky.social published today in @natureportfolio.bsky.social 🤩. A big thank you to everyone who contributed, special thank you to my partner in crime @guillemxtivill.bsky.social - it was a lot of fun to work on this together! 🥳
obenaufa.bsky.social
1/23 Big news for the #ObenaufLab! So excited to finally share our new study providing another puzzle piece, why immunotherapy fails in many tumors, now out in @Nature 🧵👇 www.nature.com/articles/s41...
Reposted by Anais Elewaut
Reposted by Anais Elewaut
obenaufa.bsky.social
The new CRISPR-StAR tool by @ulielling.bsky.social and team provides elegant new opportunities for in vivo screens. Glad we @aelewaut.bsky.social could contribute a bit.
Reposted by Anais Elewaut
obenaufa.bsky.social
Thrilled to share that our paper www.nature.com/articles/s41... is featured in a fantastic Nature News & Views piece by thomastueting.bsky.social! 🎉 Grateful for the spotlight on our research and its impact on understanding cancer immunology. www.nature.com/articles/d41... 👀👉 rdcu.be/d3cRz
A lipid made by tumour cells reprograms immune cells
Insights into how cancer cells become unresponsive to therapy.
www.nature.com
Reposted by Anais Elewaut
jboettcherlab.bsky.social
🧪Cross-Dressing intratumoral monocytes fulfill the job of cDC1s in supporting tumor-infiltrating CD8 T cells in their anti-cancer functions. Great to have contributed some 🔬&🧫 to this tour de force study by @obenaufa.bsky.social
obenaufa.bsky.social
1/23 Big news for the #ObenaufLab! So excited to finally share our new study providing another puzzle piece, why immunotherapy fails in many tumors, now out in @Nature 🧵👇 www.nature.com/articles/s41...
Reposted by Anais Elewaut
aelewaut.bsky.social
Extremely excited to see my PhD work in the @obenaufa.bsky.social published today in @natureportfolio.bsky.social 🤩. A big thank you to everyone who contributed, special thank you to my partner in crime @guillemxtivill.bsky.social - it was a lot of fun to work on this together! 🥳
obenaufa.bsky.social
1/23 Big news for the #ObenaufLab! So excited to finally share our new study providing another puzzle piece, why immunotherapy fails in many tumors, now out in @Nature 🧵👇 www.nature.com/articles/s41...
Reposted by Anais Elewaut
impvienna.bsky.social
#Immunotherapy has transformed #cancer treatment, but some cancers evade immune defenses, causing resistance.

@obenaufa.bsky.social's lab has discovered how inflammatory monocytes—a type of immune cell—can reactivate cancer-killing T cells within tumors.

Read more: imp.ac.at/news/article...
Reposted by Anais Elewaut
johannajoyce.bsky.social
Super talk at #EMDS2024 by Anna Obenauf on myeloid cell hubs for T cell interactions in cancer 👏

And this is coming out in Nature 🧪 in just a few hours - congrats to Anais, Guillem, Anna & all authors 🥳🎉

@aelewaut.bsky.social
@guillemxtivill.bsky.social
@obenaufa.bsky.social
@impvienna.bsky.social
Reposted by Anais Elewaut
labwaggoner.bsky.social
Dendritic cells maintain the CAR T cell pool in irradiated tumors
www.biorxiv.org/content/10.1...